CYBB and cancer: Not only doesthis study suggest a cellular regulatory mechanism but also indicatesthat small-molecule inhibition of the PX domain may be possible asan alternative approach to inhibition of NOX2 activity in diseasestates such as cardiovascular diseases, cancers, and neurodegenerativediseases.